Department of Internal Medicine, Boramae Medical Center, Seoul National University Hospital, Seoul, South Korea.
Department of Family Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.
PLoS One. 2023 Feb 9;18(2):e0280766. doi: 10.1371/journal.pone.0280766. eCollection 2023.
The association between abdominal visceral adipose tissue and the risk of incident chronic kidney disease according to body mass index in the Asian population, remains unclear. We evaluated the impact of abdominal adiposity stratified by body mass index on the risk of incident chronic kidney disease.
A cohort study included 11,050 adult participants who underwent health check-ups and re-evaluated the follow-up medical examination at a single university-affiliated healthcare center. Cross-sectional abdominal adipose tissue areas were measured using computed tomography. The primary outcome was progression to chronic kidney disease (estimated glomerular filtration rate <60 ml/min/1.73m2). The highest quartile of visceral adipose tissue was used for the cut-off of central obesity.
During the mean of 5.6 follow-up years, 104 incident chronic kidney disease cases were identified. The risk for chronic kidney disease incidence was significantly increased in the 3rd and 4th quartile ranges of visceral adipose tissue [hazard ratio (95% confidence interval)]: 4.59 (1.48-14.30) and 7.50 (2.33-24.20), respectively. In the analysis stratified by body mass index, the chronic kidney disease incidence risk was increased in the highest quartile range of visceral adipose tissue in the normal weight group: 7.06 (1.35-37.04). However, there was no significant relationship between visceral adipose tissue and chronic kidney disease in the obese group. Compared to the subjects with normal weight and absent central obesity, the hazard ratio for chronic kidney disease incidence was 2.32 (1.26-4.27) among subjects with normal weight and central obesity and 1.81 (1.03-3.15) among subjects with obesity and central obesity.
Visceral adipose tissue was a significant risk factor for subsequent chronic kidney disease progression, and the association was identified only in the normal weight group. Normal-weight central obesity was associated with excess risk of chronic kidney disease, similar to the risk in the group with obesity and central obesity.
在亚洲人群中,根据体重指数(BMI),腹部内脏脂肪组织与慢性肾脏病(CKD)发病风险的关系尚不清楚。我们评估了按 BMI 分层的腹部肥胖对新发 CKD 风险的影响。
这项队列研究纳入了 11050 名接受健康检查并在单一大学附属医院重新进行随访检查的成年参与者。使用计算机断层扫描测量横截面积腹部脂肪组织。主要结局为进展为慢性肾脏病(估计肾小球滤过率<60ml/min/1.73m2)。内脏脂肪组织最高四分位数用于确定中心性肥胖的切点。
在平均 5.6 年的随访期间,共发现 104 例新发 CKD 病例。内脏脂肪组织第 3 和第 4 四分位范围的 CKD 发病风险显著增加[风险比(95%置信区间)]:4.59(1.48-14.30)和 7.50(2.33-24.20)。在按 BMI 分层的分析中,正常体重组内脏脂肪组织最高四分位数范围的 CKD 发病风险增加:7.06(1.35-37.04)。然而,肥胖组内脏脂肪组织与 CKD 之间无显著关系。与体重正常且无中心性肥胖的受试者相比,体重正常且合并中心性肥胖的受试者发生 CKD 的风险比为 2.32(1.26-4.27),而肥胖且合并中心性肥胖的受试者为 1.81(1.03-3.15)。
内脏脂肪组织是随后发生 CKD 进展的一个重要危险因素,而且这种关联仅在正常体重组中观察到。正常体重的中心性肥胖与 CKD 风险增加有关,与肥胖且合并中心性肥胖的风险相似。